Lian­Bio to shut­ter, end­ing Shang­hai-based start­up’s transat­lantic am­bi­tions

Lian­Bio plans to wind down and will lay off half of its staff, it an­nounced Tues­day morn­ing.

The biotech com­pa­ny, with of­fices in Shang­hai and Prince­ton, NJ, was found­ed by Per­cep­tive Ad­vi­sors in 2019 with as­pi­ra­tions that spanned oceans. With an ex­pe­ri­enced team of deal­mak­ers, it planned to in-li­cense new and ex­per­i­men­tal med­i­cines from the US and Eu­rope to Chi­na, where it would com­plete the clin­i­cal stud­ies for ap­proval and build the com­mer­cial force need­ed to sell the drug.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER